Two classes of p38alpha MAP kinase inhibitors having a common diphenylether core but exhibiting divergent binding modes.
Article Details
- CitationCopy to clipboard
Michelotti EL, Moffett KK, Nguyen D, Kelly MJ, Shetty R, Chai X, Northrop K, Namboodiri V, Campbell B, Flynn GA, Fujimoto T, Hollinger FP, Bukhtiyarova M, Springman EB, Karpusas M
Two classes of p38alpha MAP kinase inhibitors having a common diphenylether core but exhibiting divergent binding modes.
Bioorg Med Chem Lett. 2005 Dec 1;15(23):5274-9. Epub 2005 Sep 19.
- PubMed ID
- 16169718 [ View in PubMed]
- Abstract
Two new classes of diphenylether inhibitors of p38alpha MAP kinase are described. Both chemical classes are based on a common diphenylether core that is identified by simulated fragment annealing as one of the most favored chemotypes within a prominent hydrophobic pocket of the p38alpha ATP-binding site. In the fully elaborated molecules, the diphenylether moiety acts as an anchor occupying the deep pocket, while polar extensions make specific interactions with either the adenine binding site or the phosphate binding site of ATP. The synthesis, crystallographic analysis, and biological activity of these p38alpha inhibitors are discussed.
DrugBank Data that Cites this Article
- Polypeptides
Name UniProt ID Mitogen-activated protein kinase 14 Q16539 Details - Binding Properties
Drug Target Property Measurement pH Temperature (°C) 4-(2-HYDROXYBENZYLAMINO)-N-(3-(4-FLUOROPHENOXY)PHENYL)PIPERIDINE-1-SULFONAMIDE Mitogen-activated protein kinase 14 IC 50 (nM) 6000 N/A N/A Details 4-PHENOXY-N-(PYRIDIN-2-YLMETHYL)BENZAMIDE Mitogen-activated protein kinase 14 IC 50 (nM) 1500 N/A N/A Details